Image IQ Quiz: 25-Year-Old Patient with Enlarging Breast Mass

Quiz
Article

Review the case and test your knowledge to make the correct diagnosis.

Image IQ Quiz: 25-Year-Old Patient with Enlarging Breast Mass

Case submitted by Dana Bonaminio, M.D. via Radiology Partners.

A 25-year-old, BRCA1-positive female presents with an enlarging breast mass, which is malignant. What is the most likely pathologic diagnosis?


Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound

BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound

Jeff Hall
May 14th 2025
Article

The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.

The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19

The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19

Whitney J. Palmer
November 3rd 2020
Podcast

In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.

FDA Clears AI-Powered Prostate Volume Measurement for Handheld Ultrasound

FDA Clears AI-Powered Prostate Volume Measurement for Handheld Ultrasound

Jeff Hall
April 25th 2025
Article

Offering expedited calculation of prostate volume, Clarius Prostate AI is reportedly the first AI-enabled prostate measurement tool to garner FDA clearance for use with handheld ultrasound.

Micro-Ultrasound for Easier Prostate Cancer Screening

Micro-Ultrasound for Easier Prostate Cancer Screening

Whitney J. Palmer
September 1st 2020
Podcast

Dr. Laurence Klotz discusses micro-ultrasound as a faster, less invasive, more cost-effective screening strategy compared to mpMRI in this podcast.

FDA Clears Emerging AI-Enabled Software for Cardiac Ultrasound

FDA Clears Emerging AI-Enabled Software for Cardiac Ultrasound

Jeff Hall
April 15th 2025
Article

Recent research has demonstrated that the AI software HeartFocus enabled novice health-care providers to achieve greater than 85 percent agreement with expert sonographers in assessing echocardiographic parameters.

Imaging-Based Treatment Modifications Only Used in 15 Percent of Neoadjuvant Systemic Therapy Trials for Breast Cancer

Imaging-Based Treatment Modifications Only Used in 15 Percent of Neoadjuvant Systemic Therapy Trials for Breast Cancer

Jeff Hall
April 9th 2025
Article

A systematic review of 147 clinical trials assessing neoadjuvant systemic therapy for breast cancer also revealed that mid-treatment imaging was utilized in 56 percent of the studies.

© 2025 MJH Life Sciences

All rights reserved.